View of OPTIMIZATION OF SURGICAL TREATMENT FOR PURULENT-INFLAMMATORY SOFT TISSUE DISEASES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS USING SYNERGISTIC VASODILATION AND IMMUNOCORRECTION

Return to Issue Details OPTIMIZATION OF SURGICAL TREATMENT FOR PURULENT-INFLAMMATORY SOFT TISSUE DISEASES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS USING SYNERGISTIC VASODILATION AND IMMUNOCORRECTION Download Download PDF